The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report.

Abdullah M AlrajhiSarah A AlhazzaniNouf M AlajajiFouad H AlnajjarNawal F AlshehryImran K Tailor

Published in: BMC pregnancy and childbirth (2019)

Treatment using 5-azacytadine during last trimester of pregnancy resulted in no major fetal and maternal complications. These findings concluded that 5-azacytadine during the third trimester of pregnancy seems to be safe however, potential risks of this agent should be considered.

Keyphrases

pregnancy outcomes
acute myeloid leukemia
preterm birth
pregnant women
human health
gestational age
allogeneic hematopoietic stem cell transplantation
birth weight
case report
acute lymphoblastic leukemia
climate change
physical activity
smoking cessation